| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAG2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | SOCS2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | ADA | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | PCGF5 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | ZNF37A | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-08 |
| mRNA | ZNF107 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-08 |
| mRNA | DNA2 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-08 |
| mRNA | CLK1 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | C1orf185 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | CD3G | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
